Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, said its subsidiary commenced a cash tender offer for all outstanding shares of Ariad Pharmaceuticals Inc., of Cambridge, Mass., for $24 per share. Ariad agreed earlier this month to be acquired by Takeda in a deal valued at about $5.2 billion.